LG
Ligand Pharmaceuticals, Inc.
LGNXZ · OTC
$0.00 -55.56% (-$0.00)
1M -45.65%
Market Cap $90.2K
P/E Ratio 0.00x
Div. Yield -
ROE 20.06%
Piotroski F-Score Moderate
5/9Valuation
100 /100
Cheap P/E 0.00x
P/FCF 0.00x
EV/EBITDA 0.72x
Growth
77 /100
Growing Rev. growth 17.72%
Book val. growth 8.00%
EPS growth N/A
Profitability
100 /100
Strong Gross margin 90.70%
FCF margin 45.24%
Net margin 67.88%
Quality
49 /100
Average ROIC 3.88%
Asset turnover 0.13x
ROE 20.06%
Debt
82 /100
Low Debt/Equity 1.17x
Net debt/EBITDA 0.72x
Current ratio 30.49x
Stability
31 /100
Unstable Beta 0.98x
Profitable years 2
Rev. volatility 37.46%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LGNXZ
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Todd C. Davis
Employees
47
Headquarters
Jupiter
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report